C
West Pharmaceutical Services, Inc. WST
$231.46 $1.350.59%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -5.04% -15.69% -28.24% -17.64% 33.01%
Total Depreciation and Amortization 13.37% 12.61% 14.08% 12.66% 15.43%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -110.69% -51.81% -86.79% -85.71% 306.84%
Change in Net Operating Assets -12.64% -100.40% 155.73% 26.07% -76.75%
Cash from Operations -20.49% -21.73% -2.48% -14.41% 3.60%
Capital Expenditure 3.50% 15.14% -32.89% -10.35% -14.54%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 200.00% -900.00% 85.07% -- -200.00%
Cash from Investing 3.68% 14.21% -23.26% -10.35% -14.77%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 85.71% -22,100.00% -11,580.00% 0.00% -16.67%
Issuance of Common Stock 0.00% -70.59% -44.26% 9.80% -39.22%
Repurchase of Common Stock 69.17% -86.48% -7.34% -280.45% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -3.38% -3.57% -3.55% -4.26% -4.96%
Other Financing Activities -- -- -- -- --
Cash from Financing 63.64% -188.79% -23.47% -281.69% -1,894.74%
Foreign Exchange rate Adjustments -256.55% 213.27% -266.67% -224.29% -62.63%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 85.91% -56.30% -72.89% -3,051.25% -127.04%
Weiss Ratings